Diet drug a big hit, despite the side effects

Some unpleasant side effects have done nothing to curb the public's appetite for alli, the first FDA-approved diet drug to go on sale without a prescription. The drug, a weakened version of Xenical, blocks the absorption of about 25 percent of consumed fat, which would eliminate less than 10 percent of the calories eaten in a 3,000 calorie diet. Pharmacists report that most of the buyers are women who aren't overweight and aren't at all put off by GlaxoSmithKline's recommendation that people taking the drug wear dark clothes and bring a change of clothing to work in case of an accident.

- the Los Angeles Times analyzes the sudden craze

Suggested Articles

Galecto picked up $64 million to push its lead lung disease treatment toward an approval in Europe and fund midstage studies for its other programs.

The financing, which attracted support from Roche Venture Fund, sets Palladio up to test its vasopressin V2 receptor antagonist in a kidney disease.

A new atlas of 500,000 cardiac cells could help researchers better understand how a healthy heart operates—and what goes wrong in heart disease.